Cue Health Analyst Ratings
Cue Health Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/10/2023 | 59.74% | Goldman Sachs | $0.75 → $0.5 | Maintains | Neutral |
| 06/05/2023 | 139.62% | Goldman Sachs | $2.75 → $0.75 | Maintains | Neutral |
| 06/02/2023 | 139.62% | Goldman Sachs | $2.75 → $0.75 | Downgrades | Buy → Neutral |
| 05/15/2023 | 858.47% | BTIG | $5 → $3 | Maintains | Buy |
| 05/01/2023 | 858.47% | Goldman Sachs | $3.5 → $3 | Maintains | Buy |
| 03/16/2023 | 1497.44% | BTIG | → $5 | Maintains | Buy |
| 11/14/2022 | 2136.42% | Cowen & Co. | $9 → $7 | Maintains | Outperform |
| 11/09/2022 | 2136.42% | BTIG | → $7 | Maintains | Buy |
| 10/21/2022 | 1816.93% | Goldman Sachs | $7 → $6 | Maintains | Buy |
| 08/12/2022 | 2775.4% | BTIG | $11 → $9 | Maintains | Buy |
| 08/11/2022 | 2455.91% | Morgan Stanley | $10 → $8 | Maintains | Equal-Weight |
| 05/12/2022 | 3094.89% | Morgan Stanley | $11 → $10 | Maintains | Equal-Weight |
| 03/30/2022 | 3414.38% | Morgan Stanley | $12 → $11 | Maintains | Equal-Weight |
| 10/19/2021 | 3733.87% | Morgan Stanley | → $12 | Initiates Coverage On | → Equal-Weight |
| 10/19/2021 | 5970.29% | Goldman Sachs | → $19 | Initiates Coverage On | → Buy |
| 10/19/2021 | 4372.84% | Cowen & Co. | → $14 | Initiates Coverage On | → Outperform |
| 01/03/2019 | — | Benchmark | Upgrades | Hold → Speculative Buy | |
| 11/12/2018 | — | Benchmark | Downgrades | Speculative Buy → Hold |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/10/2023 | 59.74% | 高盛 | 0.75 美元 → 0.5 美元 | 維護 | 中立 |
| 06/05/2023 | 139.62% | 高盛 | 2.75 美元 → 0.75 美元 | 維護 | 中立 |
| 06/02/2023 | 139.62% | 高盛 | 2.75 美元 → 0.75 美元 | 降級 | 買入 → 中性 |
| 05/15/2023 | 858.47% | BTIG | 5 美元 → 3 美元 | 維護 | 買 |
| 05/01/2023 | 858.47% | 高盛 | 3.5 美元 → 3 美元 | 維護 | 買 |
| 03/16/2023 | 1497.44% | BTIG | → 5 美元 | 維護 | 買 |
| 11/14/2022 | 2136.42% | Cowen & Co. | 9 美元 → 7 美元 | 維護 | 跑贏大盤 |
| 11/09/2022 | 2136.42% | BTIG | → 7 美元 | 維護 | 買 |
| 10/21/2022 | 1816.93% | 高盛 | 7 美元 → 6 美元 | 維護 | 買 |
| 2022 年 12 月 8 日 | 2775.4% | BTIG | 11 美元 → 9 美元 | 維護 | 買 |
| 08/11/2022 | 2455.91% | 摩根士丹利 | 10 美元 → 8 美元 | 維護 | 重量相等 |
| 05/12/2022 | 3094.89% | 摩根士丹利 | 11 美元 → 10 美元 | 維護 | 重量相等 |
| 03/30/2022 | 3414.38% | 摩根士丹利 | 12 美元 → 11 美元 | 維護 | 重量相等 |
| 10/19/2021 | 3733.87% | 摩根士丹利 | → 12 美元 | 啓動覆蓋範圍開啓 | → 重量相等 |
| 10/19/2021 | 5970.29% | 高盛 | → 19 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 10/19/2021 | 4372.84% | Cowen & Co. | → 14 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
| 01/03/2019 | — | 基準 | 升級 | 持有 → 投機性買入 | |
| 11/12/2018 | — | 基準 | 降級 | 投機性買入 → 持有 |
What is the target price for Cue Health (HLTH)?
Cue Health（HLTH）的目標價格是多少？
The latest price target for Cue Health (NASDAQ: HLTH) was reported by Goldman Sachs on November 10, 2023. The analyst firm set a price target for $0.50 expecting HLTH to rise to within 12 months (a possible 59.74% upside). 7 analyst firms have reported ratings in the last year.
高盛於2023年11月10日公佈了Cue Health（納斯達克股票代碼：HLTH）的最新目標股價。該分析公司將目標股價定爲0.50美元，預計HLTH將在12個月內升至12個月內（可能上漲59.74％）。去年有7家分析公司公佈了評級。
What is the most recent analyst rating for Cue Health (HLTH)?
分析師對Cue Health（HLTH）的最新評級是多少？
The latest analyst rating for Cue Health (NASDAQ: HLTH) was provided by Goldman Sachs, and Cue Health maintained their neutral rating.
Cue Health（納斯達克股票代碼：HLTH）的最新分析師評級由高盛提供，Cue Health維持中性評級。
When is the next analyst rating going to be posted or updated for Cue Health (HLTH)?
Cue Health（HLTH）的下一次分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cue Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cue Health was filed on November 10, 2023 so you should expect the next rating to be made available sometime around November 10, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Cue Health的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Cue Health的最新評級是在2023年11月10日發佈的，因此您應該預計下一個評級將在2024年11月10日左右公佈。
Is the Analyst Rating Cue Health (HLTH) correct?
分析師評級提示生命值（HLTH）是否正確？
While ratings are subjective and will change, the latest Cue Health (HLTH) rating was a maintained with a price target of $0.75 to $0.50. The current price Cue Health (HLTH) is trading at is $0.31, which is out of the analyst's predicted range.
雖然評級是主觀的，而且會發生變化，但最新的Cue Health（HLTH）評級保持不變，目標價爲0.75美元至0.50美元。Cue Health（HLTH）目前的交易價格爲0.31美元，超出了分析師的預期區間。